Radium-223 in Heavily Pretreated Metastatic Castrate-Resistant Prostate Cancer

An increasing prostate-specific antigen (PSA) level during radium therapy for metastatic castrate-resistant prostate cancer (mCRPC) is not an uncommon phenomenon, especially in heavily pretreated patients; however, an increasing PSA level does not always indicate progressive disease. Bone scan, ches...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Clin Genitourin Cancer
Autori principali: Modi, Dipenkumar, Hwang, Clara, Mamdani, Hirva, Kim, Seongho, Gayar, Hesham, Vaishampayan, Ulka, Joyrich, Richard, Heath, Elisabeth I.
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2016
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6849387/
https://ncbi.nlm.nih.gov/pubmed/27053499
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clgc.2016.03.002
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi